India Patent Cases
2,823 decisions indexed
Page 35 of 95 · 2,823 total
Huck International, Inc v.Assistant Controller Of Patents And Designs
Huck International appealed the rejection of its divisional patent application based on an objection under Section 16 of the Patents Act. The Appellant argued that they were denied a fair opportunity because the final decision was based on an objection not enumerated in the initial hearing notice. The Court agreed, setting aside the impugned order and directing the Respondent to issue a fresh notice.
PepsiCo India Holdings Pvt Ltd v.Kavitha Kuruganti
PepsiCo appealed the revocation of registration for its plant variety FL 2027. The original revocation was based on PepsiCo furnishing incorrect information about the date of first commercial sale and alleged non-compliance with documentation requirements. The High Court allowed PepsiCo's appeal, setting aside the impugned judgment regarding the eligibility to apply for registration.
F.Hoffmann-La Roche Ag v.Deputy Controller of Patents and Designs, Government of India, Patent Office
F.Hoffmann-La Roche Ag challenged the refusal of its patent application by the Deputy Controller of Patents and Designs, citing technical objections and procedural issues. The High Court found that the significant delay between the hearing and the issuance of the refusal order was arbitrary and lacked confidence.
Novartis Ag v.Natco Pharma Limited & Anr.
Novartis appealed an order that allowed certain amendments in its Indian Patent Application (IN'518) based on a finding that pre-grant opponents should be afforded an opportunity of hearing. The core dispute centered on whether the examination process and opposition proceedings are independent or merged under the Patents Act, 1970.
PepsiCo India Holdings Pvt Ltd v.Kavitha Kuruganti
This appeal challenged the revocation of a plant variety registration (FL 2027) granted to PepsiCo. The initial Single Judge affirmed the revocation primarily due to incorrect information regarding the date of first commercial sale and failure to submit requisite documentation. The High Court allowed PepsiCo's appeal, setting aside the revocation order while noting that the mistake in styling as 'new' was remediable.
M/S Star Syringe Ltd v.M/S Tiger Surgical Disposable Pvt Ltd
The plaintiffs allege that the defendants have infringed their patent and seek damages. The case is ongoing with preliminary objections raised by the defendants regarding maintainability due to insolvency proceedings.
Haryana Pesticides Manufactures Association v.Assistant Controller of Patents and Designs & Anr.
The petitioner, an association of pesticide manufacturers, challenged the dismissal of their pre-grant opposition against a patent application (No.538/DEL/2010) filed by Crystal Crop Protection Limited. The core dispute revolved around whether the respondent failed to serve notices correctly after the petitioner changed their email address.
UTI Infrastructure Technology and Services Ltd. v.Extra Tech World and Ors.
The petitioner filed a Leave Petition seeking permission from the Bombay High Court under Clause XII of the Letters Patent Act to file a Commercial Intellectual Property Rights Suit against the respondents. The core issue was establishing the court's jurisdiction, given that the infringing websites were accessible across India.
Bhabani Offset And Imaging Systems Pvt. Ltd v.Bhabani Graphics (Press) and 3 Ors.
The Gauhati High Court heard an appeal filed by Bhabani Offset And Imaging Systems Pvt. Ltd against Bhabani Graphics (Press) and others. The court admitted the appeal for hearing, directing the appellant to ensure proper service of notice on all respondents via registered post and other usual processes. The matter was subsequently listed after four weeks.
Busy Infotech Pvt Ltd v.Xpert Tricks Softwares & Ors.
This Delhi High Court order addresses an ongoing suit filed by Busy Infotech Pvt Ltd against various defendants for copyright infringement and trademark passing off related to its 'BUSY Software.' The court noted that previous interim injunctions were in place, and several pro-forma defendants had been discharged after providing undertakings. On December 8, 2023, the court directed the Plaintiff to file an updated memo of parties within one week before listing the matter again.
Kao Corporation v.The Controller Of Patents & Anr.
Kao Corporation appealed the rejection of its patent application (No. 5945/DELNP/2009) by the Joint Controller of Patents and Designs. The appeal challenged the ground that the applicant failed to file a rebuttal against non-patentability objections under Section 25(1)(f). The Court decided to issue notice to Respondent No. 2 before determining the matter.
University Health Network v.Adiuvo Diagnostics Private Limited
University Health Network filed a Writ Petition challenging the grant of Patent No.439474 to Adiuvo Diagnostics Private Limited, arguing lack of novelty and inventive step. The appeal before the Madras High Court focused on whether the court had territorial jurisdiction to hear the matter, given that the patent application originated in Delhi.
Dhama Innovations Private Limited v.The Assistant Controller of Patents and Designs, The Patent Office
Dhama Innovations Private Limited appealed the rejection of its Patent Application No. 628/CHE/2012, which related to a heat dissipation device. The appellant argued that the Controller erred by dissecting the combination into individual components for obviousness testing and failing to address their submissions on inventive step. The High Court allowed the appeal, finding the dissection impermissible in law.
Gsp Crop Science Private Limited v.Fmc Agro Singapore Pte Ltd. & Ors.
GSP Crop Science Private Limited filed a revocation petition challenging the validity of Indian patent no. 298645 (IN645) granted to FMC Agro Singapore Pte Ltd. The petitioner argued that IN645 is invalid because its main patent has expired and it suffers from anticipation by prior claims.
Natco Pharma Ltd v.Fmc Agro Singapore Pte Ltd. & Ors.
Natco Pharma Ltd filed a revocation petition challenging the validity of Indian Patent No. 314523, granted to FMC Agro Singapore Pte Ltd. & FMC Corporation. Natco argues that since the main related patent (IN 204978) expired in March 2021 and has identical claims, IN523 is invalid and liable for revocation.
Syngenta Participations Ag v.Controller Of Patents Designs
Syngenta Participations Ag filed an appeal challenging the Controller's decision to reject its Indian patent application. The rejection was based on the grounds of lacking inventive step and falling under Section 3(d) of the Patents Act, 1970. The appellant argued that sufficient data existed to prove significant enhanced efficacy under Section 3(d). The court allowed applications for condonation of delay and exemption from filing documents before directing notice and setting the matter for further hearing.
Kudos Pharmaceuticals Limited & Ors. v.Dr Reddys Laboratories Limited
The suit alleged infringement of several patents held by Kudos Pharmaceuticals Limited concerning Olaparib (LYNPARZA). The Plaintiffs contended that Dr. Reddy's Laboratories was manufacturing and exporting Olaparib API, violating their patent rights. The court decreed the suit, permanently restraining the Defendant from commercially launching the product before the patent expiry date, subject to Section 107A provisions.
Gsp Crop Science Pvt Ltd v.Synergy Insecticides Pvt Ltd
The dispute between Gsp Crop Science Pvt Ltd and Synergy Insecticides Pvt Ltd was settled out of court. The Defendant acknowledged the Plaintiff's exclusive rights in products protected by Indian Patent 394568, which covers specific formulations.
Enercon India Ltd. v.M/S. Wobben Properties GmbH
Enercon India Ltd filed a petition seeking the revocation of Indian Patent No. 220033 granted by the Controller of Patents, Chennai. Both parties submitted that the term of the said patent had expired on November 7, 2023.
Pharmacyclics, Llc & Anr. v.Natco Pharma Limited
This Delhi High Court judgment addresses a batch of patent infringement suits filed by Pharmacyclics LLC and its affiliates against various pharmaceutical companies, including Natco Pharma Limited. The core dispute revolves around the unauthorized manufacturing and marketing of Ibrutinib, a drug covered by Indian Patent 262968. The court granted interim restraint orders preventing the defendants from further manufacturing or marketing the drug while the suits are pending. However, it allowed them to exhaust existing stock under specific conditions.
Incyte Holdings Corporation v.Bdr Pharmaceuticals Internationals Private Limited
The suit was filed by Incyte Holdings Corporation and Novartis AG seeking protection of their patent (IN 269841) covering the anti-cancer drug RUXOLITINIB. The Plaintiffs alleged that the Defendant had obtained manufacturing approval for this compound, leading to a quia timet action. The Court granted an interim injunction restraining the Defendant from commercially manufacturing or launching RUXOLITINIB without court permission.
M/s. Ramcides CropScience Pvt. Ltd. v.Kingdao Agrochem (India) Private Limited
The plaintiff filed a suit alleging infringement of its patent (No. 299036) concerning 'ZINC HEDP -17%' by the defendant's product, 'Legion Zinc: Zn HEDP 17.0%'. The dispute was settled when the defendant submitted an Undertaking Affidavit agreeing to cease all infringing activities and pay compensation.
Laurus Labs Limited v.Union Of India
This judgment addresses a batch of suits alleging infringement of Indian Patent 262968, which covers the drug Ibrutinib (IMBRUVICA). The writ petition filed by Laurus Labs challenged the earlier decision of the IPAB. The Delhi High Court decided applications for interim relief in these cases. While dismissing the writ petition, the court granted an interim restraint order preventing defendants from manufacturing and marketing Ibrutinib pending final disposal of the suits, allowing them only to exhaust existing stock under strict conditions.
Largan Precision Co Ltd v.Motorola Mobility India Pvt Ltd & Ors.
The court addressed several interlocutory applications and noted that the Defendant Nos. 1 & 2 had filed a counterclaim under Section 64(1) of the Patents Act, 1970, seeking revocation of the Plaintiff's patent IN 363203.
Pharmacyclics Llc & Anr. v.Hetero Labs Limited
This judgment addresses a batch of suits filed by Pharmacyclics LLC concerning the alleged infringement of Indian Patent 262968, which covers the drug Ibrutinib (marketed as IMBRUVICA). The court heard applications for interim relief in these patent infringement cases. While dismissing one writ petition, the Delhi High Court granted an interim restraint order preventing defendants from manufacturing and marketing Ibrutinib pending final disposal of the suits. However, it allowed defendants to exhaust existing stock under specific conditions.
Pharmacyclics Llc & Anr. v.Shilpa Medicare Limited & Anr.
This judgment addresses a batch of six infringement suits filed by Pharmacyclics LLC and its affiliates against various pharmaceutical companies, including Shilpa Medicare Limited. The core dispute revolves around the alleged unauthorized manufacturing and marketing of Ibrutinib, a drug protected by Indian Patent 262968 (IN'968). The court granted interim restraint orders preventing the defendants from further manufacturing or marketing the drug pending the final disposal of the suits.
Pharmacyclics Llc & Anr. v.Hetero Labs Limited & Ors. / Natco Pharma Limited / Bdr Pharmaceuticals International Pvt Ltd / Shilpa Medicare Limited & Anr. / Alkem Laboratories Ltd
This Delhi High Court judgment addresses a batch of six suits alleging infringement of Indian Patent 262968, which covers the drug Ibrutinib. The plaintiffs sought an injunction against defendants who were launching or had launched the generic version of the patented drug. While the court dismissed one related writ petition, it granted interim relief restraining all defendants from manufacturing and marketing Ibrutinib pending the final disposal of the suits. Furthermore, the court allowed defendants to exhaust their existing stock, provided they file an affidavit detailing the batch numbers and expiry dates.
Koninklijke Philips N.V. v.Oplus Mobitech India Pvt. Ltd. & Ors.
The Plaintiff, Koninklijke Philips N.V., filed suit alleging infringement of five Indian patents covering SEPs essential to 3G/4G telecommunication standards by the Defendants, who manufacture and sell OnePlus smartphones. The court addressed an application for a pro-tem arrangement, recognizing the importance of these SEPs in industry standards.
Inventprise, Inc. v.The Controller Of Patents & Anr.
Inventprise, Inc. challenged the requirement of prior approval from the National Biodiversity Authority (NBA) concerning its patent application for a 'Heat Stable Liquid Rotavirus Vaccine.' The NBA had previously insisted on compliance with Section 6 of the Biological Diversity Act, 2002, citing the use of human rotavirus strain isolated in India. However, Inventprise argued that the subject matter did not constitute a 'biological resource' under the Act. Recognizing this core dispute, the Delhi High Court directed the NBA Expert Committee to conduct a personal hearing and issue a reasoned order on whether the invention falls within the scope of the Biological Diversity Act.
Priya Randolph v.The Deputy Controller of Patents and Designs
The appellant challenged the Controller's decision rejecting their patent application (201641026786) on the grounds that the invention was a 'business method' under Section 3(k) of the Patents Act. The court examined the claims, which related to concealing physical address information during e-commerce transactions using software and hardware. The High Court held that the monopoly claim was on a technical solution for data privacy, not merely a business method.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.